Intravenous immune globulin has effects on superantigen-induced cytokine synthesis

Infusionstherapie und Transfusionsmedizin

Volumn 23, Issue SUPPL. 4, 1996, Pages 7-14

  Andersson, J ^a,b   Fehniger, Th ^a   Bjork L ^a   Andersson, U ^a,c  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c ST GÖRAN S HOSPITAL   (Sweden)

Author keywords

cytokines; immune modulation; immune responses; intravenous immune globulin; streptococcal exotoxins; superantigens

Indexed keywords

CYTOKINE; EXOTOXIN; IMMUNOGLOBULIN G;

CONFERENCE PAPER; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INTRAVENOUS DRUG ADMINISTRATION; STREPTOCOCCUS;

STREPTOCOCCUS;

EID: 0030477478     PISSN: 10198466     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Stegmayr B, Björck S, Holm S, Nisell J, Rydvall A, Settergren B: Septic shock induced by group A streptococcal infection: Clinical and therapeutic aspects. Scand J Infect Dis 1992;24:589.
2. Stevens DL, Tanner M, Winship J, Swarts R, Ries KM, Schlievert PM, Kaplan E: Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989;321:1.
3. Chatila T, Geha RS: Superantigens. Curr Opin Immunol 1992;4:74.
4. Norrby-Teglund A, Nordgren M, Holm S, Andersson U, Andersson J: Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B. Infect Immun 1994;62:3731-3738.
5. Skansen-Saphir U, Andersson J, Andersson U: Lymphokine production induced by streptococcal pyrogenic exotoxin-A is selectively downregulated by pooled human IgG. Eur J Immunol 1994;24:916-922.
6. Heeg K: Superantigene - Bedeutung als Sepsisinduktoren. Infusionsther Transfusionsmed 1996; 23(suppl 4):15-21 (dieses Heft).
7. Leung DYM, Kurt-Jones E, Newburger JW, Cotran RS, Burns JC, Prober J: Endothelial cell activation of high IL-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet 1989;ii:1298.
8. Leung D, Meissner H, Fulton D, Murray D, Kotzin B, Schlievert P: Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1993;342:1385.
9. Takei S, Arora YK, Walker SM: Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J Clin Invest 1993;91:60.
10. Andersson U, Skansen-Saphir U, Andersson J: Downregulation of lymphokine production and IL-2 receptor expression by pooled human IgG. Immunology 1993;79:211-216.
11. Andersson JP, Andersson U: Human intravenous immunoglobulin modulates monokine production in vitro. Immunology 1990;71:372-376.
12. Andersson U, Andersson J, Lindfors A, Wagner K, Möller G, Heusser C: Simultaneous production of interleukin-2, interleukin-4 and IFN-γ by human blood lymphocytes. Eur J Immunol 1990;20:1591-1596.
13. Sander B, Andersson J, Andersson U: Assessment of cytokines by immunofluorescence and the paraformaldehyde saponin procedure. Immunol Rev 1991;119:65-93.
14. Andersson J, Nagy S, Björk L, Abrams J, Holm S, Andersson U: Bacterial toxin induced cytokine production studied at the single cell level. Immunol Rev 1992;127:89-96.
15. Poutsiaka DD, Clark D, Vannier E, Dinarello CA: Production of interleukin-1 receptor antagonist and interleukin-1b by peripheral blood mononuclear cells is differentially regulated. Blood 1991; 78:1275.
16. Schalch K, Rordorf-Adam C, Dasch JR, Jungi TW: IgG stimulated and LPS stimulated monocytes elaborate transforming growth factor b (TGF-b) in active form. Biochem Biophys Res Commun 1991;74:885.
17. Sasaki H, Pollard RB, Schmitt D, Suzuki F: Short analytical review: Transforming growth factor b in the regulation of the immune response. Clin Immunol Immunopathol 1992;65:1.
18. Björk L, Fehninger TE, Andersson U, Andersson J: Computerized assessment of multiple human cytokines at the single cell level using image analysis. J Leukocyte Biol 1996;59:287-295.
19. Montanaro A, Pirofsky B: Prolonged interval high-dose intravenous immunoglobulin in patients with primary immunodeficiency states. Am J Med 1984;76:67.
20. Radboud J, Andersson U, Brinkman B, Breedveld F, Miltenburg A: Detection of intracellular IFN-γ by light microscopy using an immuno-peroxidase technique: Correlation with the corresponding mRNA and protein product. J Leukocyte Biol 1993;54:545.
21. Andersson J, Björk L, Dinaerello C, Andersson U: Lipopolysaccharide induces human Interleukin 1 receptorantagonist- and Interleukin 1-production in the same cell. Eur J Immunol 1992;22:2617-2623.
22. Iwata M, Shimozato R, Tokiwa H, Tsubura E: Antipyretic activity of human immunoglobulin preparations for intravenous use in an experimental model of fever in rabbits. Infect Immun 1987;55:547.
23. Bussel J, Pahwa S, Porges A, CunninghamRundles S, Koziner B, Morell A, Baradun S: Correlation of in vitro antibody synthesis with the outcome of intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura. J Clin Immunol 1986;6:50.
24. Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T: Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986;324:73.
25. Roux KR, Tankersley DL: Electron microscopic and immunologic analyses of spontaneous idiotype-anti-idiotype dimers in pooled human IgG. J Immunol 1990;144:1387.